English

CHINA PEDIATRIC PHARMACEUTICALS, INC.

EDGAR

Quarterly report (10-Q) · filed 2014-05-20

38 filing records in this dataset, filed from 2006-11-24 to 2014-05-20. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.58 million USD

2014 Q1 · USD

Exact inputs and evidence

Revenue: 1581171 USD Source

Operating margin

-104.02%

2014 Q1 · %

Exact inputs and evidence

Operating Income: -1644690 USD Source
Revenue: 1581171 USD Source

Operating cash flow

3.8 million USD

2014 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: 3798690 USD Source

Cash and cash equivalents: 1.04 million USD 2014-03-31 Source
Exact value

1042707 USD
Long-term debt including current maturities: Not available
Shares outstanding: 44.6 million shares 2014-03-31 Source
Exact value

44556104 shares

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.42 million USD

2013-04-01 – 2014-03-31

Exact inputs and evidence

Revenue: 935241 USD · 2013-04-01 – 2013-06-30 Source
Revenue: 785975 USD · 2013-07-01 – 2013-09-30 Source
Revenue: 3726301 USD · 2013-01-01 – 2013-12-31 Source
Revenue: 2603699 USD · 2013-01-01 – 2013-09-30 Source
Revenue: 1581171 USD · 2014-01-01 – 2014-03-31 Source

Net income

-2.98 million USD

2013-04-01 – 2014-03-31

Exact inputs and evidence

Net income: -1179214 USD · 2013-04-01 – 2013-06-30 Source
Net income: -269562 USD · 2013-07-01 – 2013-09-30 Source
Net income: -756129 USD · 2013-01-01 – 2013-12-31 Source
Net income: -756129 USD · 2013-01-01 – 2013-09-30 Source
Net income: -1526999 USD · 2014-01-01 – 2014-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-05-20.

Financial data available through: 2013-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2013-12-31
Operating income: 5 of 11 periods available· newest 2013-12-31
Net income: 6 of 11 periods available· newest 2013-12-31
Operating cash flow: 5 of 11 periods available· newest 2012-12-31
Capital expenditure: 2 of 11 periods available· newest 2011-12-31
Total assets: 5 of 11 periods available· newest 2013-12-31
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 2013-12-31
Current liabilities: 5 of 11 periods available· newest 2013-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2013-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2013-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-73.7%

Prior period

USD 14.17 million

2012-01-01 – 2012-12-31
Current period

USD 3.73 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

3726301 − 14168261 = -10441960 USD

14168261 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
3726301 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2013-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Year-over-year change in Revenue: -10441960 USD Concept: fundies:Revenue Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3726301 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000154972714000031/cpdu-20131231.xml#49068 Filing: 000154972714000031 Input fundies:Revenue: 14168261 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000154972714000031/cpdu-20131231.xml#48937 Filing: 000154972714000031
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 8.4 million

Prior period

−USD 9.15 million

2012-01-01 – 2012-12-31
Current period

−USD 756,129

2013-01-01 – 2013-12-31

Exact inputs and evidence

-756129 − -9152318 = 8396189 USD

-9152318 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-756129 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2013-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Year-over-year change in Net income: 8396189 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -756129 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000154972714000031/cpdu-20131231.xml#34568 Filing: 000154972714000031 Input fundies:NetIncome: -9152318 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000154972714000031/cpdu-20131231.xml#34164 Filing: 000154972714000031
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2013-01-01 – 2013-12-31

Revenue USD 3.73 million 100% of revenue
Operating costs Derived USD 4.56 million 122% of revenue
Operating income −USD 835,841 −22% of revenue
Tax, interest and other Derived −USD 79,712 −2.1% of revenue
Net income −USD 756,129 −20% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 98%
2009 15%81%
2011 Operating loss: operating costs were 146% of revenue.
2012 Operating loss: operating costs were 165% of revenue.
2013 Operating loss: operating costs were 122% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	146688799	143647737 Derived	3041062	449292 Derived	2591770	Unavailable	Source 2008-01-01 – 2008-12-31: 146688799 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 3041062 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 2591770 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 241454 USD Inspect Operating Cash Flow Open source
2009 2009-01-01 – 2009-12-31	16738459	13514793 Derived	3223666	708063 Derived	2515603	Unavailable	Source 2009-01-01 – 2009-12-31: 16738459 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 3223666 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 2515603 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -498180 USD Inspect Operating Cash Flow Open source
2011 2011-01-01 – 2011-12-31	27415086	40118952 Derived	-12703866	-5737341 Derived	-6966525	-8641356 Derived	Source 2011-01-01 – 2011-12-31: 27415086 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -12703866 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -6966525 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -8636620 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 4736 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	14168261	23320419 Derived	-9152158	160 Derived	-9152318	Unavailable	Source 2012-01-01 – 2012-12-31: 14168261 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -9152158 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -9152318 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -1076648 USD Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	3726301	4562142 Derived	-835841	-79712 Derived	-756129	Unavailable	Source 2013-01-01 – 2013-12-31: 3726301 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -835841 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -756129 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.7M 2013

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	146688799	Revenue: 146688799 Open source
20092009-12-31	Revenue	16738459	Revenue: 16738459 Open source
20112011-12-31	Revenue	27415086	Revenue: 27415086 Open source
20122012-12-31	Revenue	14168261	Revenue: 14168261 Open source
20132013-12-31	Revenue	3726301	Revenue: 3726301 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-73.7% 2013

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: 146688799 Open source
20092009-12-31	Year over year	-88.6%	Revenue: 16738459 Open source Revenue: 146688799 Open source
20112011-12-31	Year over year	No prior comparable period	Revenue: 27415086 Open source
20122012-12-31	Year over year	-48.3%	Revenue: 14168261 Open source Revenue: 27415086 Open source
20132013-12-31	Year over year	-73.7%	Revenue: 3726301 Open source Revenue: 14168261 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -22.4% 2013

Net margin -20.3% 2013

Free cash flow margin -31.5% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	2.1%	Operating Income: 3041062 Open source Revenue: 146688799 Open source
20092009-12-31	Operating margin	19.3%	Operating Income: 3223666 Open source Revenue: 16738459 Open source
20112011-12-31	Operating margin	-46.3%	Operating Income: -12703866 Open source Revenue: 27415086 Open source
20122012-12-31	Operating margin	-64.6%	Operating Income: -9152158 Open source Revenue: 14168261 Open source
20132013-12-31	Operating margin	-22.4%	Operating Income: -835841 Open source Revenue: 3726301 Open source
20082008-12-31	Net margin	1.8%	Net Income: 2591770 Open source Revenue: 146688799 Open source
20092009-12-31	Net margin	15%	Net Income: 2515603 Open source Revenue: 16738459 Open source
20112011-12-31	Net margin	-25.4%	Net Income: -6966525 Open source Revenue: 27415086 Open source
20122012-12-31	Net margin	-64.6%	Net Income: -9152318 Open source Revenue: 14168261 Open source
20132013-12-31	Net margin	-20.3%	Net Income: -756129 Open source Revenue: 3726301 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 146688799 Open source Operating Cash Flow: 241454 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 16738459 Open source Operating Cash Flow: -498180 Open source
20112011-12-31	Free cash flow margin	-31.5%	Revenue: 27415086 Open source Operating Cash Flow: -8636620 Open source Capital Expenditure: 4736 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 14168261 Open source Operating Cash Flow: -1076648 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 3726301 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.1M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	241454	Operating Cash Flow: 241454 Open source
20092009-12-31	Operating cash flow	-498180	Operating Cash Flow: -498180 Open source
20112011-12-31	Operating cash flow	-8636620	Operating Cash Flow: -8636620 Open source
20122012-12-31	Operating cash flow	-1076648	Operating Cash Flow: -1076648 Open source
20132013-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -8.6M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	Unavailable	Operating Cash Flow: 241454 Open source
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: -498180 Open source
20112011-12-31	Free cash flow	-8641356	Operating Cash Flow: -8636620 Open source Capital Expenditure: 4736 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1076648 Open source
20132013-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2008-12-31	Liabilities / assets	Not reported	Total Assets: 11323953 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 15011418 Open source
2011-12-31	Liabilities / assets	Not reported	Total Assets: 22206598 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 12119512 Open source
2013-12-31	Liabilities / assets	Not reported	Total Assets: 11735690 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

19.25× 2013

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	3.3×	Current Assets: 7620976 Open source Current Liabilities: 2308629 Open source
20092009-12-31	Current assets / current liabilities	1.14×	Current Assets: 9989061 Open source Current Liabilities: 8757528 Open source
20112011-12-31	Current assets / current liabilities	12.19×	Current Assets: 19619929 Open source Current Liabilities: 1608948 Open source
20122012-12-31	Current assets / current liabilities	19.76×	Current Assets: 9881061 Open source Current Liabilities: 500048 Open source
20132013-12-31	Current assets / current liabilities	19.25×	Current Assets: 9802941 Open source Current Liabilities: 509150 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	USD 2.59 million Exact value Exact value: 2591770 USD 2008-01-01 – 2008-12-31: 2591770 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2008-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Net Income: 2591770 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2591770 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/0001127855-10-000103.txt#7499 The citation records this snapshot. The page link may show a newer release later.	USD 241,454 Exact value Exact value: 241454 USD 2008-01-01 – 2008-12-31: 241454 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2008-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Operating Cash Flow: 241454 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 241454 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/0001127855-10-000103.txt#7727 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	USD 2.52 million Exact value Exact value: 2515603 USD 2009-01-01 – 2009-12-31: 2515603 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2009-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Net Income: 2515603 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2515603 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/0001127855-10-000103.txt#7499 The citation records this snapshot. The page link may show a newer release later.	−USD 498,180 Exact value Exact value: -498180 USD 2009-01-01 – 2009-12-31: -498180 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2009-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Operating Cash Flow: -498180 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -498180 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/0001127855-10-000103.txt#7727 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	USD 5.97 million Exact value Exact value: 5971619 USD 2010-01-01 – 2010-12-31: 5971619 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2010-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Net Income: 5971619 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5971619 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101376212000833/cpdu-20111231.xml#22752 Filing: 000101376212000833 The citation records this snapshot. The page link may show a newer release later.	USD 2.95 million Exact value Exact value: 2948989 USD 2010-01-01 – 2010-12-31: 2948989 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2010-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Operating Cash Flow: 2948989 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2948989 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101376212000833/cpdu-20111231.xml#42552 Filing: 000101376212000833 The citation records this snapshot. The page link may show a newer release later.	USD 1,254 Exact value Exact value: 1254 USD 2010-01-01 – 2010-12-31: 1254 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2010-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Capital Expenditure: 1254 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1254 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101376212000833/cpdu-20111231.xml#46428 Filing: 000101376212000833 The citation records this snapshot. The page link may show a newer release later.	USD 2.95 million Calculation and evidence 2948989 − 1254 USD Exact free cash flow: 2947735 USD 2010-01-01 – 2010-12-31: 2948989 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 1254 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2010-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Free cash flow: 2947735 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2948989 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101376212000833/cpdu-20111231.xml#42552 Filing: 000101376212000833 Input fundies:CapitalExpenditure: 1254 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101376212000833/cpdu-20111231.xml#46428 Filing: 000101376212000833 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 6.97 million Exact value Exact value: -6966525 USD 2011-01-01 – 2011-12-31: -6966525 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2011-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Net Income: -6966525 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6966525 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101738613000093/cpdu-20121231.xml#53056 Filing: 000101738613000093 The citation records this snapshot. The page link may show a newer release later.	−USD 8.64 million Exact value Exact value: -8636620 USD 2011-01-01 – 2011-12-31: -8636620 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2011-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Operating Cash Flow: -8636620 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8636620 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101738613000093/cpdu-20121231.xml#102107 Filing: 000101738613000093 The citation records this snapshot. The page link may show a newer release later.	USD 4,736 Exact value Exact value: 4736 USD 2011-01-01 – 2011-12-31: 4736 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2011-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Capital Expenditure: 4736 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4736 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101376212000833/cpdu-20111231.xml#46609 Filing: 000101376212000833 The citation records this snapshot. The page link may show a newer release later.	−USD 8.64 million Calculation and evidence -8636620 − 4736 USD Exact free cash flow: -8641356 USD 2011-01-01 – 2011-12-31: -8636620 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 4736 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2011-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Free cash flow: -8641356 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8636620 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101738613000093/cpdu-20121231.xml#102107 Filing: 000101738613000093 Input fundies:CapitalExpenditure: 4736 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101376212000833/cpdu-20111231.xml#46609 Filing: 000101376212000833 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 9.15 million Exact value Exact value: -9152318 USD 2012-01-01 – 2012-12-31: -9152318 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2012-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Net Income: -9152318 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9152318 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000154972714000031/cpdu-20131231.xml#34164 Filing: 000154972714000031 The citation records this snapshot. The page link may show a newer release later.	−USD 1.08 million Exact value Exact value: -1076648 USD 2012-01-01 – 2012-12-31: -1076648 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2012-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Operating Cash Flow: -1076648 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1076648 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000101738613000093/cpdu-20121231.xml#101922 Filing: 000101738613000093 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 756,129 Exact value Exact value: -756129 USD 2013-01-01 – 2013-12-31: -756129 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA PEDIATRIC PHARMACEUTICALS, INC. · 2013-12-31 CHINA PEDIATRIC PHARMACEUTICALS, INC. (edgar:1354071) Net Income: -756129 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354071/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -756129 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354071/000154972714000031/cpdu-20131231.xml#34568 Filing: 000154972714000031 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

38 filings · 903 latest values · 903 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001354071, 1354071, edgar:1354071

Also known as CHINA PEDIATRIC PHARMACEUTICALS, INC., Lid Hair Studios International, Inc.

CHINA PEDIATRIC PHARMACEUTICALS, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2013 2013-01-01 – 2013-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation